|
|
|
|
     |
|
|
|
|
|
|
PUBLICATIONS
2005 - Present Gilron I. Analgesia controlled with patience: Towards a better understanding of analgesic self-administration behaviour. Canadian Journal of Anesthesia 2008; In Press. Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: Current evidence and future directions. Canadian Current Opinion in Anaesthesiology 2007; 20:456-472. 
Boscariol R, Gilron I, Orr E. Chronobiological characteristics of postoperative pain: diurnal variation of both static and dynamic pain and effects of analgesic therapy. Canadian Journal of Anesthesia 2007; 54:696-704.
Moulin DE, Clark AJ, Gilron I, et al. Pharmacologic Management Of Chronic Neuropathic Pain - Consensus Statement And Guidelines From The Canadian Pain Society. Pain Research Management 2007; 12:13-21.
Gilron I, Coderre TJ. Emerging drugs in neuropathic pain. Expert Opinion in Emerging Drugs 2007; 12:113-26.
Gilron I, Watson CP, Cahill CM, Moulin DE. Neuropathic pain: a practical guide for the clinician. Canadian Medical Association Journal, 2006; 102(5):1473-9.
Gilron I, Flatters SJ. Gabapentin and pregabalin for the treatment of neuropathic pain: A review of laboratory and clinical evidence. Pain Research Management 2006; 11 Suppl A:16A-29A. Gilron I. Review article: the role of anticonvulsant drugs in postoperative pain management: a bench-to-bedside perspective. Canadian Journal of Anesthesia 2006; 53:562-71.
Deshpande MA, Holden RR, Gilron I. The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction? Anesth Analg. 2006; 102:1473-9.
Odrcich M, Bailey JM, Cahill CM, Gilron I. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: diurnal pain variation and effects of analgesic therapy. Pain 2006; 120:207-12.
Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: current evidence and future directions Expert Review in Neurotherapeutics 2005; 5:823-30.
Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. New England Journal of Medicine 2005; 352:1324-34.
Gilron I, Orr E, Tu D, O'Neill JP, Zamora JE, Bell AC. A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy. Pain 2005 Jan; 113(1-2):191-200.
2000 - 2004 
Gilron I. Corticosteroids in postoperative pain management: Future research directions for a multifaceted therapy (Editorial). Acta Anaesthesiologica Scandanavica 2004;48:1221-2. Gilron I. Exploring novel drug targets in pain management: New opportunities in bench-to-bedside research. Queen's Health Sciences Journal 2004; 7:28-32. Hansen C, Gilron I, Hong M. Effects of intrathecal gabapentin on spinal morphine tolerance in the rat tail-flick and paw pressure tests. Anesthesia & Analgesia 2004 Oct; 99(4):1180-4.
Gilron I. Gabapentin (Editorial). CNS Drugs 2003; 17:983-4.
Gilron I, Milne B, Hong M. Cyclooxygenase-2 inhibitors in postoperative pain management: Current evidence and future directions. Anesthesiology 2003; 99:1198-208. Gilron I, Biederman J, Jhamandas K, Hong M. Gabapentin blocks, and reverses, antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests. Anesthesiology 2003; 98:1288-92. Gilron I. Gabapentin: the first preemptive anti-hyperalgesic for opioid withdrawal hyperalgesia? In Reply (letter). Anesthesiology 2003; 98:1520-2. Gilron I, Bailey JM. Trends in opioid use for chronic neuropathic pain: A survey of patients pursuing enrollment in clinical trials. Canadian Journal of Anesthesia, 2003; 50:42-47.
Gilron I, Tod D, Goldstein DH, Parlow JL, Orr E. The relationship between evoked versus spontaneous pain and peak expiratory flow after abdominal hysterectomy. Anesthesia & Analgesia, 2002; 95(6):1702-7.
Gilron I. Is gabapentin a "broad spectrum" analgesic? (Editorial). Anesthesiology 2002; 97:537-9.
Gilron I, Bailey JM, Weaver DF, Houlden RL. Patients' attitudes and prior treatments in neuropathic pain: A pilot study. Pain Research & Management 2002; 7(4):199-203.
Sang CN, Booher SL, Gilron I, Parada S, Max MB. Dextromethorphan and Memantine in Painful Diabetic Neuropathy and Postherpetic Neuralgia: Efficacy and Dose-Response Trials. Anesthesiology 2002; 96:1053-61.
Gilron I. Therapeutic potential of the AMPA/kainate receptor antagonist LY293558 in the management of pain and other central nervous system disorders. Current Opinions in Investigational Drugs 2001; 2:1273-1278.
Max MB, Gilron I. Antidepressants, muscle relaxants, and NMDA receptor antagonists in: Bonica's Management of Pain, 3rd Edition, JD Loeser, D Turk, CR Chapman, S Butler, Editors Williams & Wilkins, 2001. Coghill RC, Gilron I, Iadarola MJ. Hemispheric lateralization of somatosensory processing. Journal of Neurophysiology 2001; 85:2602.
Gilron I, Booher SL, Rowan JS, Max MB. Topiramate in Trigeminal Neuralgia: A Randomized, Placebo-Controlled Multiple Crossover Pilot Study. Clinical Neuropharmacology 2001; 24:109-12.
Gilron I, Booher SL, Rowan JS, Smoller B, Max MB. A randomized controlled trial of high-dose dextromethorphan in facial neuralgias. Neurology 2000; 55:964-71.
Gilron I, Max MB, Lee G, Booher SL, Sang CN, Chappell AS, Dionne RA. Effects of the AMPA/kainate antagonist LY293558 on spontaneous and evoked postoperative pain. Clinical Pharmacology and Therapeutics 2000; 68:320-7.
Gilron I. Neural blockade in the evaluation and management of chronic pain: An overview. Pain Research & Management 2000; 5:93-100. 1987-1999
Gilron I, Quirion R, Coderre TJ. Pre- versus post-formalin effects of Ketamine or large-dose Alfentanil in the rat: Discordance between pain behavior and spinal fos-like immunoreactivity (FLI). Anesthesia and Analgesia 1999; 89:128-35.
Max MB, Gilron I. Sympathetically-maintained pain: Has the emperor no clothes? (Editorial). Neurology 1999; 52:905-7.
Gilron I, Quirion R, Coderre TJ. Pre- versus post-injury effects of intravenous gabaergic anesthetics on formalin-induced fos immunoreactivity in the rat spinal cord.
Gilron I, Plourde G, Marcantoni W, Varin F. The 40-Hz auditory steady-state response and EEG spectral edge frequency during sufentanil anaesthesia. Canadian Journal of Anaesthesia 1998; 45:115.
Gilron I, Coderre TJ. Novel targets of pain modulation in anaesthesia: Preventing painful memories (editorial). Canadian Journal of Anaesthesia. 1997; 44:457-462.
Backman SB, Gilron I, Robbins GR. Protamine and its cardiovascular effects - Reply (letter). Canadian Journal of Anaesthesia 1997; 44:1323. Backman S, Gilron I, Robbins GR. Protamine-induced bradycardia in a previous heart transplant recipient. Canadian Journal of Anaesthesia 1997; 44:520-524.
Gilron I, Coderre TJ. Is Pentobarbital analgesic in the rat formalin test? In Reply:(letter) Anesthesiology 1997; 86:266-267. Gilron I, Coderre TJ. Preemptive analgesic effects of steroid anesthesia with alphaxalone in the rat formalin test: Evidence for differential gamma-aminobutyric acidA receptor modulation in persistent nociception. Anesthesiology 1996; 84:572-579.
Gilron I, Solomon P, Plourde G. Unintentional intraoperative awareness during high dose sufentanil anesthesia for cardiac surgery. Canadian Journal of Anaesthesia 1996; 43:295-8.
Gilron I, Magder S. Case Report: Monitoring complication due to a pulsatile femoral vein from tricuspid regurgitation. Canadian Journal of Anaesthesia 1995; 42:141-3.
Gilron I. The introduction of new drugs into anaesthetic practice: A perspective in pharmaceutical development and regulation. Canadian Journal of Anaesthesia 1995; 42:516-22.
Gilron I, Scott WAC, Slinger P, Wilson JAS. Case report: contralateral lung soiling following laser resection of a bronchial tumour. Journal of Cardiothoracic and Vascular Anesthesia 1994; 8:567-569.
Gilron I. Anaesthesia equipment safety in Canada: the role of government regulation. Canadian Journal of Anaesthesia 1993; 40:987-92.
Wiesel S., Gilron I. Portex epidural catheters (letter). Canadian Journal of Anaesthesia 1993; 40:397-8.
Gilron I. The Emergency Drug Release Program: Regulatory aspects of new drug access in Canada. Canadian Medical Association Journal 1993; 148:1151-3.
Baer HH, Gilron I. Preparation of some carbohydrate pyrazolines by cycloaddition of diazomethane to nitroalkenic sugars. Carbohydrate Research 1987; 164:486-92.
| |
|
|
||
|
|
|
Copyright: Department of Anesthesiology, Queen's University. All rights reserved | Disclaimer. Website developed and maintained by WhiteSpaceNorth.com. |
